English | Español
Patient Daily | Apr 23, 2026

Biopharma obesity and diabetes deals surpass last year’s total in first quarter of 2026
Patient Daily | Apr 23, 2026

MeiraGTx buys back rights to eye disease gene therapy from Johnson & Johnson
Patient Daily | Apr 23, 2026

Lilly’s Foundayo shows positive diabetes trial results and no liver safety concerns
Patient Daily | Apr 23, 2026

European Life Sciences Coalition launches to address investment challenges in biotech sector
Patient Daily | Apr 23, 2026

Study finds superficial skin exposures may increase rabies risk
Patient Daily | Apr 23, 2026

ICER calls for greater transparency in FDA’s accelerated approval program
Patient Daily | Apr 23, 2026

St. Jude researchers develop organoid models for pediatric brain tumor studies
Patient Daily | Apr 23, 2026

Cochrane review finds anti-amyloid drugs show little benefit for Alzheimer's patients

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2026

FDA seen as more flexible under acting commissioner Kyle Diamantas
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science